http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007284377-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b842f49ddb6c195b14fa56d8a27c686f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04
filingDate 2006-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aff31ced1299441cb24f555c94e8c6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c67cfb4e34204ed305f21a4aae94745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_585b6f9e1d9e72c2a0629d6a0990efc9
publicationDate 2007-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2007284377-A
titleOfInvention Colombidin compounds and antitumor agents
abstract The present invention provides a novel compound having cytotoxic activity against human cancer cells and hardly causing harm to normal cells, and an antitumor agent comprising these as active ingredients. The following general formula (I): (Wherein R1 represents a hydrogen atom, a chain or branched hydrocarbon group, a cyclic hydrocarbon group, or an aromatic hydrocarbon group, and R2 to R8 each independently represent a hydrogen atom, a chain or a branched group. A hydrocarbon group, a cyclic hydrocarbon group, an aromatic hydrocarbon group, a halogen atom, a sulfonic acid group, an alkoxy group, a phenoxy group, an alkoxycarbonyl group, a carboxyl group, a benzoyl group, a lower acyl group or a nitrile group) Or a pharmacologically acceptable salt thereof. Moreover, it is an antitumor agent which uses the said colombidin compound or its pharmacologically acceptable salt as an active ingredient. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102329323-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023167310-A1
priorityDate 2006-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID7729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11560227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49864366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426344731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457630696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID179269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419528286
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID7729
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466300413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426105809

Total number of triples: 35.